by Plataforma LAC | Dec 5, 2019 | About the response against AIDS, TB and Malaria, News
Source: paho.org 7 November 2019 – The municipality of Puerto Lempiras is located in a dense jungle that is only accessible by water transport, or by aircraft. The Miskito Indians are the predominant ethnic group in the area, where most malaria cases in the...
by Plataforma LAC | Dec 5, 2019 | About the response against AIDS, TB and Malaria, News
Source: stoptb.org The Stop TB Partnership’s Global Drug Facility catalog now lists the first-ever, all-oral regimen forhighly resistant forms of drug-resistant tuberculosis at US $1,040 per treatment course. 28 October 2019 I Hyderabad, India. With unprecedented...
by Plataforma LAC | Dec 5, 2019 | About the response against AIDS, TB and Malaria, News
Source: lacfondomundial.org This report presents the results of the survey on experiences and opinions regarding the processes and arrangements supported by the Global Fund in the LAC Region. It was launched jointly by the LAC constituency and the HTCG (Horizontal...
by Plataforma LAC | Dec 5, 2019 | About the fund, News
Source: aidspan.org Author: Christelle Boulanger and Atiqa Chajai A reflection on the need to review the CCM model and better adapt it to a country’s reality and objectives When the Global Fund was born… When the Global Fund was born as a response to an...
by Plataforma LAC | Dec 5, 2019 | About the fund, News
Source: theglobalfund.org HYDERABAD, India – A landmark agreement announced today by Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria and global biopharmaceutical company Sanofi will significantly lower the price of rifapentine, a critically important...
